The European Society of Cardiology (ESC) is making important changes to the editorial focus of the EP Europace journal. This peer-reviewed journal covers original scientific work in the fields of pacing, arrhythmias, and cardiac electrophysiology, and has a 2011 Impact Factor rating of 1.839.
In a move designed to align content with the needs of the wider electrophysiology profession, EP Europace becomes the official journal to three of the ESC’s communities; the European Heart Rhythm Association (EHRA), the ESC Working Group (WG) on Cardiac Cellular Electrophysiology, and the ESC Working Group on e-Cardiology.
Effective January 2012, EP Europace will additionally invite articles on research topics into the application of computing technology and data processing for electrophysiology. This new area recognises the growing importance of computing in respect of electrophysiology-related medical equipment performance, simulations, registries and surveys, and database management. It also complements the established clinical practice and basic science focus of EP Europace that is covered by the specialities of the EHRA and WG on Cardiac Cellular Electrophysiology respectively.
Commenting on the change, Angelo Auricchio, EHRA president, said: “I am delighted that the EHRA and the WGs on Cardiac Cellular Electrophysiology and e-Cardiology have agreed to co-operate. It is vital that we build on EP Europace’s excellent reputation for original content and continually review the relevance of coverage. I thank all the scientists and physicians who have contributed to past successes, and especially welcome the new editorial team that will guide this excellent journal to be the best source for original scientific work in electrophysiology from around the world.”
John Camm remains editor-in-chief and is supported by a new EP Europace editorial board. Antonio Zaza becomes deputy editor, Basic and Experimental Science, with Stefano Severi and Godfrey Smith as associate editors. Philippe Chevalier becomes associate editor, e-Cardiology, with Angel Moya and Pedro Brugada appointed as Translational and Clinical Associate editors.